Related Experiment Video
Updated: Jun 5, 2025

09:55
In vitro Cell Migration and Invasion Assays
Published on: June 1, 2014
137.9K
Integrin α1 upregulation by TF:FVIIa complex promotes cervical cancer migration through PAR2-dependent MEK1/2
Nagarajan Paranitharan1, Shivangi Kataria1, Vijaya Anand Arumugam2
1Department of Biotechnology, Bharathiar University, Coimbatore, India.
Biochemical and Biophysical Research Communications
|December 10, 2024
Summary
The tissue factor (TF):FVIIa complex activates protease-activated receptor 2 (PAR2) signaling, increasing integrin α1 expression and promoting cervical cancer cell migration. This TF:FVIIa:PAR2 pathway offers potential therapeutic targets for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Tissue factor (TF) and protease-activated receptor 2 (PAR2) are implicated in cancer progression.
- Integrins are crucial for cancer cell adhesion and migration.
Purpose of the Study:
- To investigate the crosstalk between the TF:FVIIa complex, PAR2 signaling, and integrin α1 expression in cervical cancer.
- To elucidate the role of this pathway in cancer cell migration.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA) data for gene correlations.
- Western blotting and RT-PCR to assess protein and gene expression.
- Functional cell migration assays and pathway inhibition studies.
Main Results:
- Positive correlation found between integrin α1 (ITGA1) and both TF and PAR2 genes in reproductive cancers.
- TF:FVIIa complex transactivates PAR2, leading to MEK1/2 phosphorylation and increased integrin α1 expression.
- Inhibition of PAR2 or MEK1/2 reduced FVIIa-induced integrin α1 expression; blocking integrin α1 inhibited cell migration.
Conclusions:
- A novel signaling pathway involving TF:FVIIa:PAR2 axis modulating integrin α1 in cervical cancer cells was identified.
- This pathway significantly enhances cancer cell migration.
- Targeting the TF:FVIIa:PAR2 axis or downstream integrins may offer new therapeutic strategies for cancer.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Activation of Integrins
3.3K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.3K
Integrins
3.8K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
3.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K

